Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

From FDA to LATAM: How Pure Global Helps Navigate the COFEPRIS Medical Device Pathway in Mexico for Faster Market Access

3:36
 
Share
 

Manage episode 501852326 series 3684625
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
This episode of LATAM MedTech Insights dives deep into the medical device approval process in Mexico, governed by the regulatory body COFEPRIS. We demystify the requirements, from device classification to the critical role of a local registration holder, providing a clear roadmap for international MedTech companies looking to enter this lucrative market. We explore the strategic pathways that can save you valuable time and resources. Discover how leveraging your existing approvals from bodies like the US FDA or Health Canada can dramatically accelerate your journey to market, transforming a potentially lengthy process into a streamlined and predictable one. A US-based scaleup with a novel Class II device faced this exact scenario. Their initial submission was stalled for over a year due to documentation errors and a lack of a clear strategy, costing them valuable time and market opportunity. This episode reveals how leveraging an often-overlooked equivalency pathway could have cut their approval time in half and avoided costly mistakes. Key Takeaways from this episode: 1. What are the four main risk classifications for medical devices in Mexico? 2. How can you use your existing FDA or Health Canada approval to speed up COFEPRIS registration? 3. What is a Mexican Registration Holder (MRH), and why is choosing the right one critical to your business's future? 4. What common documentation mistakes lead to costly delays with COFEPRIS? 5. How does the new "Abbreviated Pathway" coming in 2025 change the game for manufacturers? 6. Is it better to use your distributor as your MRH, or an independent third party? 7. What are the specific post-market surveillance requirements you must meet in Mexico? At Pure Global, we offer end-to-end regulatory consulting solutions for MedTech and IVD companies, combining local expertise with advanced AI to streamline global market access. We act as your local representative in over 30 markets, including Mexico, to get your product approved and maintain compliance. Contact us to learn how we can accelerate your entry into the LATAM market at [email protected] or visit us at https://pureglobal.com/.
  continue reading

23 episodes

Artwork
iconShare
 
Manage episode 501852326 series 3684625
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
This episode of LATAM MedTech Insights dives deep into the medical device approval process in Mexico, governed by the regulatory body COFEPRIS. We demystify the requirements, from device classification to the critical role of a local registration holder, providing a clear roadmap for international MedTech companies looking to enter this lucrative market. We explore the strategic pathways that can save you valuable time and resources. Discover how leveraging your existing approvals from bodies like the US FDA or Health Canada can dramatically accelerate your journey to market, transforming a potentially lengthy process into a streamlined and predictable one. A US-based scaleup with a novel Class II device faced this exact scenario. Their initial submission was stalled for over a year due to documentation errors and a lack of a clear strategy, costing them valuable time and market opportunity. This episode reveals how leveraging an often-overlooked equivalency pathway could have cut their approval time in half and avoided costly mistakes. Key Takeaways from this episode: 1. What are the four main risk classifications for medical devices in Mexico? 2. How can you use your existing FDA or Health Canada approval to speed up COFEPRIS registration? 3. What is a Mexican Registration Holder (MRH), and why is choosing the right one critical to your business's future? 4. What common documentation mistakes lead to costly delays with COFEPRIS? 5. How does the new "Abbreviated Pathway" coming in 2025 change the game for manufacturers? 6. Is it better to use your distributor as your MRH, or an independent third party? 7. What are the specific post-market surveillance requirements you must meet in Mexico? At Pure Global, we offer end-to-end regulatory consulting solutions for MedTech and IVD companies, combining local expertise with advanced AI to streamline global market access. We act as your local representative in over 30 markets, including Mexico, to get your product approved and maintain compliance. Contact us to learn how we can accelerate your entry into the LATAM market at [email protected] or visit us at https://pureglobal.com/.
  continue reading

23 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play